Sarcopenic obesity and the risk of hospitalization or death from coronavirus disease 2019: findings from UK Biobank
Abstract Background Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. The role of skeletal muscle mass in modulating immune response is well documented. Whilst obesity is well established as a key factor in COVID‐19 and outcome, n...
Saved in:
Main Authors: | Thomas J. Wilkinson (Author), Thomas Yates (Author), Luke A. Baker (Author), Francesco Zaccardi (Author), Alice C. Smith (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study
by: Thomas J. Wilkinson, et al.
Published: (2021) -
UK biobank: Enhanced assessment of the epidemiology and long-term impact of coronavirus disease-2019
by: Qi Feng, et al.
Published: (2023) -
Sarcopenia, long‐term conditions, and multimorbidity: findings from UK Biobank participants
by: Richard M. Dodds, et al.
Published: (2020) -
Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study
by: Shiyong Zhang, et al.
Published: (2024) -
Muscle strength and incidence of depression and anxiety: findings from the UK Biobank prospective cohort study
by: Verónica Cabanas‐Sánchez, et al.
Published: (2022)